Thoughtful psychiatric care. Portsmouth, NH.
A comprehensive psychiatric practice offering a range of treatments — not limited to a single approach. The same careful, individualized care applied to every patient.
Spravato® (esketamine) is an FDA-approved nasal spray for treatment-resistant depression — typically for patients who have tried two or more antidepressants without adequate relief. It works on different brain pathways and is administered in-office under physician supervision.
Dr. David Schopick has spent more than 30 years in clinical practice, working with patients navigating mood disorders, anxiety, ADHD, trauma, OCD, and treatment-resistant depression. His approach combines careful diagnostic work with conservative, individualized prescribing.
He sees patients from childhood through adulthood — and has spent his career building the kind of practice where the same physician is there for every appointment, every crisis, and every milestone.
“The patients I see most often are the ones who have already tried multiple medications and other treatments. They’ve been through multiple providers, and they’re exhausted. My job isn’t to start over from scratch — it’s to look more carefully at what hasn’t worked and why, and to bring options to the table they may not have had access to yet.”
— David J. Schopick, M.D.We offer telepsychiatry by video for evaluations and ongoing medication management. Spravato® is available in-office for treatment-resistant depression.
HIPAA-compliant video visits for initial evaluations and ongoing medication management. All you need is a smartphone with audio and video capabilities — making it easy to keep appointments from wherever you are. Available to patients whose primary residence is in NH or MA.
Dr. Schopick is in-network with the following primary insurances:
Send us a note. Vicki, our office manager, responds personally.